Skip to main content
. 2023 Nov 11;9(11):e22245. doi: 10.1016/j.heliyon.2023.e22245

Fig. 3.

Fig. 3

Number of patients receiving PIM prescriptions by category according to the STOPP-J criteria, shown separately for patients with sarcopenia only and those with co-MS. *Drugs prescribed significantly more frequently to patients with co-MS than to patients with sarcopenia only (p-value<0.05). PIM, potentially inappropriate medication; STOPP-J, Screening Tool for Older Person's Appropriate Prescriptions for Japanese; co-MS, malnutrition and sarcopenia.